Kooperativer Bibliotheksverbund

UID:

Format: 1 online resource (823 pages)

Edition: 1st ed.

ISBN: 0-12-398280-4

Note: Bibliographic Level Mode of Issuance: Monograph , Front Cover -- Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders -- Copyright -- Dedication -- Contents -- Preface -- References -- Acknowledgments -- List of Contributors -- Chapter 1 - An Introduction: A Clinical Neuroscientist and Disorders of the Brain -- INTRODUCTION -- LOCALIZATION OF LESIONS -- IMAGING -- SELECTIVE VULNERABILITY OF NEURONAL POPULATIONS -- RECOVERY AFTER INJURY -- STEM CELLS IN RECOVERY -- BRAIN TRANSPLANTS -- NEUROLOGY AS A THERAPEUTIC FIELD -- ANIMAL MODELS OF HUMAN DISEASE -- DEVELOPMENT OF NEW DRUGS -- CLINICAL TRIALS -- TRIALS IN ALZHEIMER DISEASE -- BIOMARKERS OF DISEASE -- PSYCHIATRIC DISEASE -- GENETICS OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS -- TEMPERAMENT AND DISEASE -- CONCLUSION -- References -- Section I - DEVELOPMENTAL DISORDERS -- Chapter 2 - Introduction -- Chapter 3 - Developmental Disabilities and Metabolic Disorders -- INTRODUCTION -- BRAIN DEVELOPMENT -- FUNCTIONAL DEVELOPMENT -- ETIOLOGY -- TECHNIQUES -- PRINCIPLES OF MANAGEMENT -- PRACTICE GUIDELINES -- CONCLUSION -- QUESTIONS FOR FURTHER RESEARCH -- References -- Chapter 4 - Attention Deficit/Hyperactivity Disorder -- INTRODUCTION -- CLINICAL DESCRIPTION -- NEUROIMAGING STUDIES -- EFFECTS OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER TREATMENTS ON BRAIN FUNCTION -- SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY AND POSITRON EMISSION TOMOGRAPHY STUDIES -- CURRENT CLINICAL APPLICATIONS OF NEUROIMAGING STUDIES -- FUTURE PERSPECTIVES IN THE NEUROIMAGING OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER -- EXPERIMENTAL ANIMAL MODELS -- CONCLUSION -- QUESTIONS FOR FURTHER RESEARCH -- References -- Chapter 5 - Down Syndrome: A Model for Chromosome Abnormalities -- INTRODUCTION -- DOWN SYNDROME -- MOUSE MODELS OF DOWN SYNDROME -- CLINICAL CHARACTERIZATION OF DOWN SYNDROME -- DEVELOPMENT OF PHARMACOTHERAPY IN DOWN SYNDROME. , CONCLUSION AND REMAINING ISSUES -- Acknowledgments -- References -- Chapter 6 - Autism Spectrum Disorder -- INTRODUCTION -- HISTORY -- CLINICAL FEATURES -- DEFINITION AND CLASSIFICATION -- EPIDEMIOLOGY -- NATURAL HISTORY -- DIFFERENTIAL DIAGNOSIS -- ASSESSMENT -- NEUROPSYCHOLOGICAL PROFILE/COGNITIVE FUNCTIONING -- NEUROBIOLOGY -- NEUROIMAGING -- NEUROPHYSIOLOGY -- NEUROPATHOLOGY -- NEUROCHEMISTRY -- GENETIC AND ENVIRONMENTAL RISK FACTORS -- TREATMENT -- FUTURE DIRECTIONS -- Acknowledgment -- References -- Chapter 7 - Rett Syndrome: From the Involved Gene(s) to Treatment -- INTRODUCTION -- CLINICAL FEATURES OF RETT SYNDROME AND OTHER MECP2-RELATED DISORDERS -- DIAGNOSIS AND CLINICAL MANAGEMENT OF RETT SYNDROME -- GENETICS OF RETT SYNDROME: MECP2 GENE, PATHOGENIC MUTATIONS, AND PHENOTYPIC OUTCOME -- MECP2 MOUSE MODELS RECAPITULATING HUMAN MECP2-RELATED PATHOLOGIES -- MECP2 EXPRESSION DURING BRAIN DEVELOPMENT: ROLE IN NEURONAL MATURATION AND/OR MAINTENANCE OF THE MATURE STATE -- NEUROMORPHOLOGICAL AND NEUROPHYSIOLOGICAL CONSEQUENCES OF MECP2 DYSFUNCTION -- RETT SYNDROME: NOT SOLELY A NEURONAL DISEASE -- MECP2: A MULTIFUNCTIONAL PROTEIN WHOSE PATHOGENIC MECHANISMS REMAIN UNSOLVED -- MECP2 RESEARCH: FROM BENCH TO BEDSIDE -- CONCLUSION AND FUTURE CHALLENGES -- Acknowledgments -- References -- Chapter 8 - Fragile X-Associated Disorders -- INTRODUCTION -- RNA TOXICITY IN PREMUTATION CARRIERS -- FRAGILE X SYNDROME -- CLINICAL MANIFESTATIONS OF THE FRAGILE X PREMUTATION -- PSYCHIATRIC MORBIDITY OF THE FRAGILE X PREMUTATION -- CONCLUSION -- AREAS FOR FUTURE RESEARCH -- Acknowledgments -- References -- Section II - DISEASES OF THE PERIPHERAL NERVOUS SYSTEM -- Chapter 9 - Introduction -- Chapter 10 - Myasthenia Gravis -- INTRODUCTION -- IMMUNOPATHOGENESIS -- DEFECT IN NEUROMUSCULAR TRANSMISSION -- ANIMAL MODELS OF MYASTHENIA GRAVIS -- EPIDEMIOLOGY AND GENETICS. , CLINICAL PHENOTYPE -- DIAGNOSIS -- TREATMENT -- CONCLUSION -- References -- Chapter 11 - Muscular Dystrophy -- INTRODUCTION -- PATHOPHYSIOLOGY AND GENETICS -- EPIDEMIOLOGY -- CLINICAL MANIFESTATIONS -- DIAGNOSIS -- GENETIC COUNSELING -- TREATMENT AND OUTCOMES -- CONCLUSION -- Acknowledgments -- References -- Chapter 12 - Peripheral Neuropathies -- PERIPHERAL NERVOUS SYSTEM BIOLOGY -- CLINICAL MANIFESTATION AND DIAGNOSTIC MODALITIES IN PERIPHERAL NEUROPATHIES -- INHERITED NEUROPATHIES -- IMMUNE-MEDIATED NEUROPATHIES -- OTHER NEUROPATHIES -- CONCLUSION -- QUESTIONS FOR FURTHER RESEARCH -- References -- Chapter 13 - Diabetes and Cognitive Dysfunction -- DIABETES MELLITUS -- COMPLICATIONS ASSOCIATED WITH DIABETES -- UNDERLYING MECHANISMS LINKING DIABETES AND ALZHEIMER DISEASE -- ANIMAL MODELS OF DIABETES AND ALZHEIMER DISEASE -- CONCLUSION -- Acknowledgments -- References -- Section III - DISEASES OF THE CENTRAL NERVOUS SYSTEM AND NEURODEGENERATION -- Chapter 14 - Introduction -- Chapter 15 - Spinal Cord Injury -- INTRODUCTION -- TYPES OF INJURY AND GLIAL SCAR FORMATION -- TIME-COURSE OF POSTINJURY CHANGES -- CELL TYPES INVOLVED -- ROLE OF THE EXTRACELLULAR MATRIX AND GROWTH INHIBITORS -- CELL DEATH FOLLOWING SPINAL CORD INJURY -- GENETIC AND EPIGENETIC CONTROL OF AXONAL GROWTH -- INFLAMMATORY AND MALADAPTIVE IMMUNE RESPONSES AND THE BLOOD-BRAIN BARRIER -- NEUROPATHIC PAIN AND AUTONOMIC DYSREFLEXIA -- THERAPEUTIC TOOLS IN SPINAL CORD INJURY -- QUESTIONS FOR FURTHER RESEARCH -- References -- Chapter 16 - Traumatic Brain Injury -- INTRODUCTION: EPIDEMIOLOGY AND CLASSIFICATIONS -- PRIMARY EFFECTS OF TRAUMATIC BRAIN INJURY -- SECONDARY EFFECTS OF TRAUMATIC BRAIN INJURY -- CHRONIC EFFECTS OF TRAUMATIC BRAIN INJURY -- CONCLUSION -- DIRECTIONS FOR FUTURE RESEARCH -- Acknowledgments -- References -- Chapter 17 - Epilepsy -- INTRODUCTION. , CLASSIFICATION OF THE SEIZURES AND THE EPILEPSIES -- MECHANISMS UNDERLYING SEIZURES -- MECHANISMS OF EPILEPTOGENESIS AND EPILEPSY -- TREATMENT OF EPILEPSY -- SUMMARY -- Acknowledgments -- References -- Chapter 18 - Amyotrophic Lateral Sclerosis -- INTRODUCTION -- DIAGNOSIS OF AMYOTROPHIC LATERAL SCLEROSIS -- CLINICAL CHARACTERISTICS OF AMYOTROPHIC LATERAL SCLEROSIS -- NATURAL HISTORY OF AMYOTROPHIC LATERAL SCLEROSIS -- AVAILABLE TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS -- NEUROBIOLOGICAL BASIS OF AMYOTROPHIC LATERAL SCLEROSIS -- MODEL SYSTEMS OF AMYOTROPHIC LATERAL SCLEROSIS TOXICITY -- FUTURE DIRECTIONS -- Acknowledgments -- References -- Chapter 19 - Parkinson Disease and Other Synucleinopathies -- INTRODUCTION -- CLINICAL FEATURES OF PARKINSON DISEASE -- DIAGNOSIS OF PARKINSON DISEASE -- ETIOLOGY OF PARKINSON DISEASE: CLUES FROM EPIDEMIOLOGY AND GENETICS -- TREATMENT OF PARKINSON DISEASE -- CONCLUSION -- References -- Chapter 20 - Huntington Disease -- OVERVIEW OF HUNTINGTON DISEASE -- ANIMAL MODELS OF HUNTINGTON DISEASE -- NEUROPATHOLOGY OF HUNTINGTON DISEASE -- NEUROBIOLOGY OF HUNTINGTON DISEASE -- TREATMENT OF HUNTINGTON DISEASE -- OTHER CAG REPEAT DISORDERS -- QUESTIONS FOR FURTHER RESEARCH -- References -- Chapter21 - Alzheimer Disease -- INTRODUCTION -- NEUROPATHOLOGY OF ALZHEIMER DISEASE -- GENETICS AND MOLECULAR BIOLOGY OF ALZHEIMER DISEASE -- CURRENT AND FUTURE THERAPIES FOR ALZHEIMER DISEASE -- CONCLUSION -- QUESTIONS FOR FURTHER RESEARCH -- Acknowledgments -- References -- Chapter 22 - Cerebrovascular Disease - Stroke -- DEFINITION OF STROKE -- BRAIN LESIONS CAUSED BY CEREBROVASCULAR DISEASE -- VASCULAR PATHOLOGIES CAUSING BRAIN ISCHEMIA AND HEMORRHAGE -- FACTORS AFFECTING TISSUE SURVIVAL IN PATIENTS WITH BRAIN ISCHEMIA AND INFARCTION -- DEATH OF CELLS IN THE CNS, AND NEUROPROTECTIVE AND REPARATIVE MECHANISMS. , QUESTIONS FOR FURTHER RESEARCH -- References -- Chapter 23 - Prion Diseases -- INTRODUCTION -- CAUSES AND PATHOGENESIS OF PRION DISEASES -- KURU -- CREUTZFELDT-JAKOB DISEASE -- VARIANT CREUTZFELDT-JAKOB DISEASE -- GERSTMANN-STRÄUSSLER-SCHEINKER DISEASE -- LABORATORY TESTS -- CONCLUSION -- QUESTIONS FOR FURTHER RESEARCH -- References -- Section IV - INFECTIOUS AND IMMUNE-MEDIATED DISEASES AFFECTING THE NERVOUS SYSTEM -- Chapter 24 - Introduction -- Chapter 25 - Role of Inflammation in Neurodegenerative Diseases -- INTRODUCTION -- MICROGLIA: CONVERGENCE POINT FOR PROMOTING OR COMPROMISING NEURONAL SURVIVAL -- T-LYMPHOCYTES: NEUROPROTECTION AND NEUROTOXICITY -- PARKINSON DISEASE -- ALZHEIMER DISEASE -- AMYOTROPHIC LATERAL SCLEROSIS -- CONCLUSION -- References -- Chapter 26 - Role of Inflammation in Psychiatric Disease -- INTRODUCTION -- EVIDENCE THAT THE IMMUNE SYSTEM IS INVOLVED IN PSYCHIATRIC DISEASE PATHOGENESIS -- EVIDENCE THAT PATTERNS OF CNS ACTIVITY ASSOCIATED WITH PSYCHIATRIC DISEASE AFFECT IMMUNE FUNCTIONING IN HEALTH-RELEVANT WAYS -- EVIDENCE THAT ENVIRONMENTAL FACTORS THAT PROMOTE PSYCHIATRIC MORBIDITY MAY DO SO BY ALTERING IMMUNE FUNCTION -- EVIDENCE THAT PSYCHIATRIC CONDITIONS ARE ASSOCIATED WITH ALTERATIONS IN PERIPHERAL AND CNS IMMUNE ACTIVITY -- References -- Chapter 27 - Infections and Nervous System Dysfunction -- INTRODUCTION -- MICROBE-HOST CELL INTERACTIONS -- IMMUNE RESPONSES TO INVADING PATHOGENS -- INVASION OF PATHOGENS IN THE NERVOUS SYSTEM -- PATHOGENS CAUSING NERVOUS SYSTEM DYSFUNCTION -- FUTURE DIRECTIONS -- Acknowledgments -- References -- Chapter 28 - Pathobiology of CNS Human Immunodeficiency Virus Infection -- INTRODUCTION -- HUMAN IMMUNODEFICIENCY VIRUS GENETICS AND GENOMIC ORGANIZATION OF HIV-1 -- LIFE CYCLE OF THE HUMAN IMMUNODEFICIENCY VIRUS -- ESTABLISHMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION. , ENTRY OF HUMAN IMMUNODEFICIENCY VIRUS INTO THE CNS. , English

Additional Edition: ISBN 0-12-398270-7

Language: English

Keywords: Electronic books.

URL: Click to View

UID:

Format: 1 Online-Ressource.

Note: Neurobiology of Brain Disorders is the first book directed primarily at basic scientists to offer a comprehensive overview of neurological and neuropsychiatric disease. This book links basic, translational, and clinical research, covering the genetic, developmental, molecular, and cellular mechanisms underlying all major categories of brain disorders. It offers students, postdoctoral fellows, and researchers in the diverse fields of neuroscience, neurobiology, neurology, and psychiatry the tools they need to obtain a basic background in the major neurological and psychiatric diseases, and to discern connections between basic research and these relevant clinical conditions. This book addresses developmental, autoimmune, central, and peripheral neurodegeneration; infectious diseases; and diseases of higher function. The final chapters deal with broader issues, including some of the ethical concerns raised by neuroscience and a discussion of health disparities. Included in each chapter is coverage of the clinical condition, diagnosis, treatment, underlying mechanisms, relevant basic and translational research, and key unanswered questions. Written and edited by a diverse team of international experts, Neurobiology of Brain Disorders is essential reading for anyone wishing to explore the basic science underlying neurological and neuropsychiatric diseases. Links basic, translational, and clinical research on disorders of the nervous system, creating a format for study that will accelerate disease prevention and treatment. Covers a vast array of neurological disorders, including ADHD, Down syndrome, autism, muscular dystrophy, diabetes, TBI, Parkinson, Huntington, Alzheimer, OCD, PTSD, schizophrenia, depression, and pain. Illustrated in full color. Each chapter provides in-text summary points, special feature boxes, and research questions. Provides an up-to-date synthesis of primary source material

Additional Edition: Erscheint auch als Druckschrift ISBN 978-0-12-398270-4

Language: English

DOI: 10.1016/C2009-0-63918-0

URL: Volltext  (URL des Erstveröffentlichers)

URL: Volltext  (URL des Erstveröffentlichers)

UID:

Format: XIV, 577 S. : , Ill., graph. Darst.

ISBN: 0-89004-737-5

Series Statement: Advances in neurology 36

Language: English

Keywords: Myatrophische Lateralsklerose ; Motoneuron ; Motoneuron ; Krankheit ; Konferenzschrift ; Congress ; Konferenzschrift ; Konferenzschrift

UID:

Format: XIX, 895 S. : Ill., graph. Darst.

Series Statement: (International congress series 404)

Note: Literaturangaben

Language: Undetermined

UID:

Format: XII, 470 S. , Ill., graph. Darst.

ISBN: 0683002430

Series Statement: Research publications / Association for Research in Nervous and Mental Disease 49

Language: English

UID:

Format: XVII, 481 S. : Ill.

ISBN: 0-19-505163-7

Language: English

Keywords: Neuromuskuläre Krankheit ; Molekulargenetik

UID:

Format: xii, 346 p. : , ill.

Edition: Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.

Note: Originally published: Bethesda, Md. : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, [2001]. , Birth -- First steps -- Development -- Directors of NINDS -- The scientific directors -- Intramural program -- Extramural program -- Training -- Big tickets: collaborative and field studies -- Decade of the brain: David Mahoney and the Dana Alliance for Brain Initiatives -- The voluntaries -- Five Lasker awards and six Nobels -- Seymour S. Kety, M.D. -- Louis Sokoloff, M.D. -- Nancy S. Wexler, Ph.D. -- Roscoe O. Brady, M.D. -- D. Carleton Gajdusek, M.D. -- Stanley B. Prusiner, M.D. -- Celebrating the synapse -- Julius Axelrod, Ph.D. -- Arvid Carlsson, M.D. -- Paul Greengard, Ph.D. -- Eric R. Kandel, M.D. -- One brain science, genomics, the clinical neurosciences, and the future of NINDS -- A neuroscience timeline -- Fifty years of advances in neuroscience.

Language: English

Keywords: Electronic books.

URL: Click to View

UID:

Format: XVII, 964 S. : , zahlr. Ill., graph. Darst.

Edition: 8. ed.

ISBN: 0-8121-1148-6

Note: Literaturangaben

Language: English

Subjects: Medicine

Keywords: Neurologie ; Nervensystem ; Krankheit

UID:

Format: 1 Online-Ressource.

Note: Neurobiology of Brain Disorders is the first book directed primarily at basic scientists to offer a comprehensive overview of neurological and neuropsychiatric disease. This book links basic, translational, and clinical research, covering the genetic, developmental, molecular, and cellular mechanisms underlying all major categories of brain disorders. It offers students, postdoctoral fellows, and researchers in the diverse fields of neuroscience, neurobiology, neurology, and psychiatry the tools they need to obtain a basic background in the major neurological and psychiatric diseases, and to discern connections between basic research and these relevant clinical conditions. This book addresses developmental, autoimmune, central, and peripheral neurodegeneration; infectious diseases; and diseases of higher function. The final chapters deal with broader issues, including some of the ethical concerns raised by neuroscience and a discussion of health disparities. Included in each chapter is coverage of the clinical condition, diagnosis, treatment, underlying mechanisms, relevant basic and translational research, and key unanswered questions. Written and edited by a diverse team of international experts, Neurobiology of Brain Disorders is essential reading for anyone wishing to explore the basic science underlying neurological and neuropsychiatric diseases. Links basic, translational, and clinical research on disorders of the nervous system, creating a format for study that will accelerate disease prevention and treatment. Covers a vast array of neurological disorders, including ADHD, Down syndrome, autism, muscular dystrophy, diabetes, TBI, Parkinson, Huntington, Alzheimer, OCD, PTSD, schizophrenia, depression, and pain. Illustrated in full color. Each chapter provides in-text summary points, special feature boxes, and research questions. Provides an up-to-date synthesis of primary source material

Additional Edition: Erscheint auch als Druckschrift ISBN 978-0-12-398270-4

Language: English

DOI: 10.1016/C2009-0-63918-0

URL: Volltext  (URL des Erstveröffentlichers)

UID:

Format: 1 online resource (1194 pages) : , illustrations

Edition: Twelfth edition / editors, Lewis P. Rowland, Timothy A. Pedley.

Note: Signs and symptoms in neurologic diagnosis: approach to the patient -- Delirium and confusion -- Memory loss, behavioral changes and dementia -- Aphasia, apraxia, and agnosia -- Syncope, seizures and their mimics -- Coma -- Headache -- Diagnosis of pain and paresthesias -- Dizziness, vertigo, and hearing loss -- Impaired vision -- Involuntary movements -- Syndromes caused by weak muscles -- Gait disorders -- CT and MRI -- Electroencephalography and evoked potentials -- Electromyography, nerve conduction studies, and and magnetic stimulation -- Autonomic testing -- Neurovascular imaging -- Endovascular neuroradiology -- Lumbar puncture and cerebrospinal fluid examination -- Muscle and nerve biopsy -- Neuropsychological evaluation -- DNA diagnosis -- Bacterial infections -- Focal infections -- Viral infections and postviral syndromes -- Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) -- Fungal infections -- Neurosarcoidosis -- Neurosyphilis -- Leptospirosis -- Lyme disease -- Parasitic infections -- Bacterial toxins -- Prion diseases -- Whipple disease -- Pathogenesis, classification, and epidemiology of cerebrovascular disease -- Examination of the patient with cerebrovascular disease -- Transient ischemic attack -- Cerebral infarction -- Intracerebral hemorrhage -- Genetics of stroke -- Other cerebrovascular syndromes -- Differential diagnosis of stroke -- Stroke in children -- Treatment and prevention of stroke -- Subarachnoid hemorrhage -- Cerebral venous and sinus thrombosis -- Vascular disease of the spinal cord -- Vasculitis -- Susac syndrome -- Vascular tumors and malformations -- Hydrocephalus -- Normal pressure hydrocephalus (NPH) -- Brain edema and disorders of intracranial pressure -- Superficial siderosis and intracerebral hypotension -- Hyperosmolar syndromes -- General considerations -- Tumors of the skull and cranial nerves -- Tumors of the meninges -- Gliomas -- Lymphomas -- Pineal region tumors -- Tumors of the pituitary gland -- Congenital and childhood tumors -- Metastatic tumors -- Spinal tumors -- Paraneoplastic syndromes -- Complications of cancer chemotherapy -- , Head injury -- Spine injury -- Cranial and peripheral nerve lesions -- Complex regional pain syndrome -- Radiation injury -- Electrical and lightning injury -- Decompression sickness -- Intervertebral dics and radiculopathy -- Cervical spondylotic myelopathy -- Thoracic outlet syndrome -- Hereditary and acquired spastic paraplegia -- Syringomyelia -- Neonatal neurology -- Floppy infant syndrome -- Disorders of motor and mental development -- Autism spectrum disorders -- Laurence-Moon-Biedl syndrome -- Cerebral and spinal malformations -- Chromosomal diseases -- Marcus Gunn -- Möbius syndrome -- Disorders of amino acid metabolism -- Disorders of purine and pyrimidine metabolism -- Lysosomal and other storage diseases -- Disorders of carbohydrate metabolism -- Glucose transporter type 1 deficiency syndrome -- Disorders of DNA maintenance, transcription, and translation -- Hyperammonemia -- Peroxisomal diseases: adrenoleukodystrophy, zellweger syndrome, and refsum disease -- Organic acidurias -- Disorders of metal metabolism -- Acute intermittent porphyria -- Neurologic syndromes with acanthocytes -- Cerebral degenerations of childhood -- Diffuse sclerosis and vanishing white matter disease -- Mitochondrial encephalomyopathies: diseases of mitochondrial DNA -- Leber hereditary optic neuropathy -- Mitochondrial diseases with mutations of nuclear DNA -- Neurofibromatosis -- Tuberous sclerosis complex -- Encephalotrigeminal angiomatosis -- Incontinentia pigmenti -- General considerations -- Alzheimer disease -- Frontotemporal dementia -- Lewy body dementias -- Huntington disease -- Choreas -- Myoclonus -- Gilles de la tourette syndrome -- Dystonia -- Essential tremor -- Parkinson disease -- Parkinson-plus syndromes -- Paroxysmal dyskinesias -- Tradive dyskinesia and other neuroleptic-induced syndromes -- Autosomal recessive ataxias -- Autosomal dominant ataxias -- Amyotrophic lateral sclerosis, progressive muscular atrophy, and primary lateral sclerosis -- Kennedy disease -- Spinal muscular atrophies of childhood -- Monomelic muscular atrophy -- General considerations -- The inherited peripheral neuropathies -- Acquired neuropathies -- Neuropathic pain -- Myasthenia gravis -- Lambert-Eaton syndrome -- Botulism and antibiotic-induced neuromuscular disorders -- Critical illness myopathy and neuropathy -- Identifying disorders of the motor unit -- , Progressive muscular dystrophies -- Familial periodic paralysis -- Congenital disorders of muslce -- Myoglobinuria -- Muscle cramps and stiffness -- Dermatomyositis -- Polymyositis, inclusion body myositis, and related myopathies -- Myositis ossificans -- Multiple sclerosis -- Neuromyelitis optica -- Marchiafava-Bignami disease -- Central pontine myelinolysis -- Epilepsy -- Febrile seizures -- Primary and secondary headaches -- Transient global amnesia -- Ménière syndrome -- Sleep disorders -- Neurogenic orthostatic hypotension, autonomic failure, and autonomic neuropathy -- Familial dysautonomia -- Endocrine diseases -- Hematologic and related diseases -- Hepatic disease -- Cerebral complications of cardiac surgery -- Bone disease -- Renal disease -- Respiratory support for neurologic diseases -- Nutritional disorders: malnutrition, malabsorption, and B₁₂ and other vitamin deficiency -- Hypertrophic pachymeningitis -- Neurologic disease during pregnancy -- Hashimoto encephalopathy -- Schizophrenia -- Mood disorders -- Anxiety disorders -- Somatoform disorders -- Alcoholism -- Drug dependence -- Iatrogenic disease -- Occupational and environmental neurotoxicology -- HIV, fetal alcohol and drug effects, and the battered child -- Falls in the elderly -- Neurologic rehabilitation -- End-of-life issues in neurology.

Additional Edition: Print version: Merritt's neurology. Philadelphia, PA : Lippincott Williams & Wilkins, [2010] ISBN 9780781791861

Language: English

Keywords: Electronic books.

URL: Click to View